Passer au contenu principal

Chemical Entities of Biological Interest Ontology (CHEBI)

Choisissez le vocabulaire dans lequel chercher

  • Aide
aligner
annoter
télécharger

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > organonitrogen heterocyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organonitrogen heterocyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > sulfur molecular entity > organosulfur compound > organosulfur heterocyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organosulfur compound > organosulfur heterocyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organosulfur compound > organosulfur heterocyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organosulfur heterocyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organosulfur heterocyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organosulfur heterocyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organosulfur heterocyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organosulfur heterocyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > heteropolycyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > polycyclic compound > heteropolycyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > heterobicyclic compound > organic heterobicyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > bicyclic compound > heterobicyclic compound > organic heterobicyclic compound > benzothiazepine > 2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione

Terme préférentiel

2-phenyl-3,5-dihydro-2H-1,5-benzothiazepine-4-thione  

Concept générique

Appartient au groupe

URI

http://data.loterre.fr/ark:/67375/KFP-Z86KQ63L-Q

Télécharger ce concept :

RDF/XML TURTLE JSON-LD